Publications
Original Article
TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy
Tumor Microenvironment
2011
Authors:
Lu H., Yang Y., Gad E., Inatsuka C., Wenner C. A., Disis M. L., Standish L. J.
Journal:
Clinical Cancer Research
Volume:
17(21)
Page:
6742-53
Pubmed:
Original Article
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen
Cancer Vaccines
2010
Authors:
Karyampudi L, Krco CJ, Kalli KR, Erskine CL, Hartmann LC, Goodman K, Ingle JN, Maurer MJ, Nassar A, Yu C, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, and Knutson KL
Journal:
Cancer Immunology, Immunotherapy
Volume:
59(1)
Page:
161-71
Pubmed:
Original Article
Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment
Tumor Microenvironment
2010
Authors:
Kievit F. M., Florczyk S. J., Leung, M. C., Veiseh, O., Park, J. O., Disis, M. L., Zhang, M.
Journal:
Biomaterials
Volume:
31(22)
Page:
5903-10
Pubmed:
Original Article
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
Cancer Vaccines
2010
Authors:
Olson B. M., Frye T. P., Johnson L. E., Fong L., Knutson K. L., Disis M. L., McNeel D. G.
Journal:
Cancer Immunology Immunotherapy
Volume:
59(6)
Page:
943-53
Pubmed:
Original Article
Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade
Tumor Microenvironment
2010
Authors:
Lu H., Wagner W. M., Gad E., Yang Y., Duan H., Amon L. M., Van Denend N., Larson E. R., Chang A., Tufvesson H., Disis M. L.
Journal:
The Journal of Immunology
Volume:
184(9)
Page:
5360-7
Pubmed:
Original Article
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102
Cancer Vaccines
2010
Authors:
Karyampudi, L., Formicola, C., Erskine, C. L., Maurer, M. J., Ingle, J. N., Krco, C. J., Wettstein, P. J., Kalli, K. R., Fikes, J. D., Beebe, M., Hartmann, L. C., Disis, M. L., Ferrone, S., Ishioka, G., Knutson, K. L.
Journal:
Clinical Cancer Research
Volume:
16(3)
Page:
825-34
Pubmed:
Original Article
Toward a stem cell gene therapy for breast cancer
General Immune Research
2009
Authors:
Li Z, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem HP, Disis ML, Lieber A.
Journal:
Blood
Volume:
113(22)
Page:
5423-5433
Pubmed:
Original Article
Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer
Cancer Vaccines
2009
Authors:
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA, Dela Rosa C, Tietje K, Link J, Waisman J, Salazar LG.
Journal:
Journal of Clinical Oncology
Volume:
27(28)
Page:
4685-92
Pubmed:
Original Article
In situ adenovirus vaccination engages T effector cells against cancer
Cancer Vaccines
2009
Authors:
Tuve S, Liu Y, Tragoolpua K, Jacobs JD, Yumul RC, Li ZY, Strauss R, Hellstrom KE, Disis ML, Roffler S, Lieber A.
Journal:
Vaccine
Volume:
27(31)
Page:
4225-39
Pubmed:
Original Article
Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity
Cancer Vaccines
2009
Authors:
Coveler AL, Goodell V, Webster DJ, Salazar LG, Fintak PA, Childs JS, Higgins DM and Disis ML
Journal:
Breast Cancer Research and Treatment
Volume:
113(1)
Page:
95-100
Pubmed: